Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - August 2017

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Desmopressin (Noqdirna®) has been accepted for restricted in the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults. The restriction limits use to adults aged 65 years and over.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - August 2017' on Email Share 'SMC Update - August 2017' on Delicious Share 'SMC Update - August 2017' on Digg Share 'SMC Update - August 2017' on Facebook Share 'SMC Update - August 2017' on reddit Share 'SMC Update - August 2017' on StumbleUpon Share 'SMC Update - August 2017' on Twitter

atomic-wealth

No Comments to “SMC Update - August 2017”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer